Epstein-Barr virus-associated mononucleosis caused by weekly low-dose methotrexate therapy in a rheumatoid arthritis patient.
Shoda
H
H
Nakazaki
K
K
Izutsu
K
K
Tanaka
R
R
Komagata
Y
Y
Misaki
Y
Y
Yamamoto
K
K
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001853:Bone Marrow / Q000473:pathology; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007244:Infectious Mononucleosis / Q000139:chemically induced* / Q000175:diagnosis / Q000821:virology; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D016133:Polymerase Chain Reaction; D014057:Tomography, X-Ray Computed
D004279:DNA, Viral; D007166:Immunosuppressive Agents; D008727:Methotrexate